NDC 51672-4177

Keveyis

Dichlorphenamide

Keveyis is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Taro Pharmaceuticals U.s.a., Inc.. The primary component is Dichlorphenamide.

• Product ID: 51672-4177_822bc66c-a00b-4e14-9ad9-0d2ab2fe9956
• NDC: 51672-4177
• Product Type: Human Prescription Drug
• Proprietary Name: Keveyis
• Generic Name: Dichlorphenamide
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2015-08-07
• Marketing Category: NDA / NDA
• Application Number: NDA011366
• Labeler Name: Taro Pharmaceuticals U.S.A., inc.
• Substance Name: DICHLORPHENAMIDE
• Active Ingredient Strength: 50 mg/1
• Pharm Classes: Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [CS],Carbonic Anhydrase Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51672-4177-1

100 TABLET in 1 BOTTLE (51672-4177-1)

• Marketing Start Date: 2015-08-07
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51672-4177-1 [51672417701]

Keveyis TABLET

• Marketing Category: NDA
• Application Number: NDA011366
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-08-07

Drug Details

Active Ingredients

Ingredient	Strength
DICHLORPHENAMIDE	50 mg/1

OpenFDA Data

• SPL SET ID: 4e274191-b1fc-43df-af35-beb5bbacc16c
• Manufacturer:
  • Taro Pharmaceuticals U.S.A., inc.
• UNII:
  • VVJ6673MHY
• RxNorm Concept Unique ID - RxCUI:
  • 1661799
  • 197594
• UPC Code:
  • 0351672417710

Pharmacological Class

• Carbonic Anhydrase Inhibitors [MoA]
• Sulfonamides [CS]
• Carbonic Anhydrase Inhibitor [EPC]

NDC Crossover Matching brand name "Keveyis" or generic name "Dichlorphenamide"

NDC	Brand Name	Generic Name
51672-4177	Keveyis	Dichlorphenamide
71090-001	Keveyis	Dichlorphenamide
72065-001	Keveyis	Dichlorphenamide
51672-4144	DARANIDE	dichlorphenamide
13668-676	Dichlorphenamide	Dichlorphenamide